DVC1-0101 to treat peripheral arterial disease: a Phase I/IIa open-label dose-escalation clinical trial.
暂无分享，去创建一个
Y. Maehara | Y. Nakanishi | Y. Yonemitsu | H. Inoguchi | M. Hasegawa | H. Ban | M. Shimokawa | M. Inoue | Kumi Yoshida | Takuya Matsumoto | Michiko Tanaka | M. Onimaru | T. Onohara | J. Okazaki | R. Kyuragi | H. Itoh | M. Uchiyama | T. Shu | M. Inoue